Approvals (Drugs@FDA)

DASATINIB

ZYDUS PHARMS · DASATINIB

ANDA218719Generic (ANDA)Prescription
Open FDA's page for this record
Application number
ANDA218719
Sponsor name
ZYDUS PHARMS
Submissions
  1. Submission type
    ORIG
    Submission number
    1
    Submission status
    AP
    Submission status date
    20250303
    Review priority
    STANDARD
    Submission class code
    UNKNOWN
Products
  1. Product number
    006
    Reference drug
    No
    Brand name
    DASATINIB
    Reference standard
    No
    Dosage form
    TABLET
    Route
    ORAL
    Marketing status
    Prescription
    Te code
    AB
    Active ingredients
    1. Name
      DASATINIB
      Strength
      140MG
  2. Product number
    004
    Reference drug
    No
    Brand name
    DASATINIB
    Reference standard
    No
    Dosage form
    TABLET
    Route
    ORAL
    Marketing status
    Prescription
    Te code
    AB
    Active ingredients
    1. Name
      DASATINIB
      Strength
      80MG
  3. Product number
    002
    Reference drug
    No
    Brand name
    DASATINIB
    Reference standard
    No
    Dosage form
    TABLET
    Route
    ORAL
    Marketing status
    Prescription
    Te code
    AB
    Active ingredients
    1. Name
      DASATINIB
      Strength
      50MG
  4. Product number
    005
    Reference drug
    No
    Brand name
    DASATINIB
    Reference standard
    No
    Dosage form
    TABLET
    Route
    ORAL
    Marketing status
    Prescription
    Te code
    AB
    Active ingredients
    1. Name
      DASATINIB
      Strength
      100MG
  5. Product number
    003
    Reference drug
    No
    Brand name
    DASATINIB
    Reference standard
    No
    Dosage form
    TABLET
    Route
    ORAL
    Marketing status
    Prescription
    Te code
    AB
    Active ingredients
    1. Name
      DASATINIB
      Strength
      70MG
  6. Product number
    001
    Reference drug
    No
    Brand name
    DASATINIB
    Reference standard
    No
    Dosage form
    TABLET
    Route
    ORAL
    Marketing status
    Prescription
    Te code
    AB
    Active ingredients
    1. Name
      DASATINIB
      Strength
      20MG
Harmonized identifiers (openFDA)
Application number
ANDA218719
Brand name
DASATINIB
Generic name
DASATINIB
Manufacturer name
Zydus Pharmaceuticals USA Inc., Zydus Lifesciences Limited
Product NDC
70710-1741, 70710-1742, 70710-1743, 70710-1744, 70710-1745, 70710-1746, 70771-1901, 70771-1902, 70771-1903, 70771-1904, 70771-1905, 70771-1906
Product type
HUMAN PRESCRIPTION DRUG
Route
ORAL
Substance name
DASATINIB
RxCUI
643105, 643107, 643109, 799047, 1045402, 1045406
SPL ID
46121457-8af5-4016-827f-ead2f0b33b83, 571889d7-845d-4fed-8d7d-6470d4d36fa1
SPL set ID
11703145-29ea-480a-9810-bc70663b783f, 4eed6b7b-a09d-4d2e-a345-968dd68323bc
Package NDC
70710-1741-6, 70710-1742-6, 70710-1743-6, 70710-1744-3, 70710-1745-3, 70710-1746-3, 70771-1901-6, 70771-1902-6, 70771-1903-6, 70771-1904-3, 70771-1905-3, 70771-1906-3
UNII
RBZ1571X5H
Wholesale access for licensed clinicians.

Free to join: your NPI is checked against the federal registry at signup, then wholesale pricing and the professional shelves open.

Join as a DoctorSell on MedGrid

Data from openFDA, FDA's public API. FDA says not to rely on it to make decisions about medical care and to treat every result as unvalidated; confirm against FDA's own record and the product labeling. Not medical or legal advice.